Project Grant K01DA065495
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $172K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
North Andover, MA 01845, USA
Similar Awards
- The National Institute on Drug Abuse awarded Trustees of Boston University $193,751 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a career development research initiative examining quality of care in outpatient substance use disorder treatment facilities. The award funds a five-year training and research plan designed to develop the principal investigator as an independent substance use disorder services researcher. The research uses a novel...
- The National Institute on Drug Abuse awarded Massachusetts General Hospital $197,640 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a four-year project examining the clinical impact and cost-effectiveness of integrating infectious disease care into rapid-access substance use bridge clinics. The research addresses the syndemic of substance use disorder and infections among people who inject drugs, who face elevated risk of overdose, acute bacterial...
- The National Institute on Drug Abuse awarded The General Hospital Corporation (Massachusetts General Hospital) $197,281 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a virtual, group-based multicomponent mind-body intervention for tobacco cessation in adults with serious mental illness. The intervention integrates mind-body skills and social support with gold-standard tobacco treatment—medication and counseling—delivered as a 12-week protocol...
- The National Institute on Drug Abuse awarded The Medical University of South Carolina $249,000 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate how social-contextual stressors affect smoking cessation and relapse among socioeconomically disadvantaged young adults who smoke. The recipient will conduct mixed-methods research combining qualitative interviews and ecological momentary assessment (EMA) to examine the lived experiences of...
- The National Institute on Drug Abuse awarded Yale University $190,580 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and pilot a multiple health behavior change intervention targeting concurrent weight loss and smoking cessation among pre-bariatric surgery patients. The award funds a pilot randomized controlled trial enrolling 64 adult pre-surgical patients with severe obesity who smoke. The intervention arm (32 participants) will complete a 4-month...
- The National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health, awarded the University of California, San Diego $192,930 in project grant funding on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports mentoring in patient-oriented research on central nervous system dysfunction in individuals with HIV and substance use. The funded activities provide protected time for the principal...
- The National Institute on Drug Abuse, a component of the Department of Health and Human Services National Institutes of Health, awarded Brown University $350,000 on July 1, 2026, for Project Grant R01DA061886 under the Biomedical Research and Research Training program (CFDA 93.859). The award funds a randomized controlled clinical trial examining a multiple health behavior change intervention for adults with obesity who smoke cigarettes. The study will enroll 220 participants with BMI of 30 or...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...
- The National Institute on Drug Abuse awarded Hennepin Healthcare Research Institute $193,320 on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support development of a mentored career development award (K01) focused on improving behavioral healthcare for mothers with opioid use disorder, their children, and families. The award funds a five-year research initiative through June 30, 2031, based in Minneapolis, Minnesota. The investigator will develop a strategy...
- The National Institute on Drug Abuse awarded the University of California, San Diego $200,297 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support Dr. Nicole Kelly's mentored career development as a postdoctoral fellow transitioning to independent investigator status. The award funds Dr. Kelly's structured training program in implementation science and policy evaluation focused on expanding access to long-acting injectable treatments for HIV and opioid...